Levobupivacaine is an amide local anesthetic that can increase the threshold of nerve action potential, delay the expansion of nerve impulses, and reduce the speed of action potential increase, thereby blocking the generation and conduction of nerve impulses. The generation of anesthetic effects is related to the axial diameter, myelin formation and conduction velocity of nerve fibers.

By binding to DNA molecules, it inhibits nucleic acid synthesis and causes cell death. This product is a non-specific drug for the cell cycle. It has no complete cross-resistance with anthracycline drugs.

Nedaplatin is a cisplatin analogue that binds to DNA after entering cells and inhibits DNA replication, thereby producing anti-tumor activity. The base site at which it binds to DNA is the same as that of cisplatin.

Nedaplatin is a cisplatin analogue that binds to DNA after entering cells and inhibits DNA replication, thereby producing anti-tumor activity. Its binding mode and base site to DNA are the same as those of cisplatin.